Grace Therapeutics (GRCE) Stock Chart & Stock Price History $3.35 +0.01 (+0.30%) As of 07/17/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock Grace Therapeutics Stock Price Performance The Grace Therapeutics (GRCE) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 10.43%. In the past month, the stock has increased 9.12%, reflecting recent market activity. As of the latest close, Grace Therapeutics traded at $3.35 with a market cap of $46.33 million and volume of 30,659 shares. Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-2.62%1 Month Performance+9.12%3 Month Performance+60.29%Year-To-Date Performance-10.43% GRCE Stock Chart for Friday, July, 18, 2025 GRCE Chart by TradingView Grace Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/17/2025$3.34$3.35+0.30%$3.45$3.2830,659 shs$46.33 million07/16/2025$3.19$3.34+4.70%$3.35$3.1060,258 shs$46.19 million07/15/2025$3.31$3.19-3.63%$3.41$3.1552,402 shs$44.12 million07/14/2025$3.44$3.31-3.78%$3.74$3.29127,399 shs$45.78 million07/11/2025$3.10$3.44+10.97%$3.50$3.07155,956 shs$47.58 million07/10/2025$3.07$3.10+0.98%$3.15$3.0532,877 shs$42.87 million07/09/2025$3.04$3.07+0.99%$3.15$2.99107,228 shs$42.46 million07/08/2025$3.00$3.04+1.33%$3.07$3.00111,749 shs$42.04 million07/07/2025$3.13$3.00-4.15%$3.10$2.9742,106 shs$41.49 million07/04/2025$3.13$3.13$3.17$3.0128,627 shs$43.29 million Get the Latest News and Ratings for GRCE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 07/03/2025$3.02$3.13+3.64%$3.17$3.0128,627 shs$43.29 million07/02/2025$2.96$3.02+2.03%$3.03$2.9850,362 shs$41.76 million07/01/2025$2.97$2.96-0.34%$3.00$2.9416,034 shs$40.94 million06/30/2025$2.97$2.97$3.00$2.9119,137 shs$41.08 million06/27/2025$2.94$2.97+1.02%$2.99$2.9121,118 shs$30.12 million06/26/2025$2.96$2.94-0.68%$3.01$2.9235,194 shs$29.81 million06/25/2025$3.00$2.96-1.33%$3.10$2.9588,389 shs$30.01 million06/24/2025$2.93$3.00+2.39%$3.04$2.9184,372 shs$30.42 million06/23/2025$3.00$2.93-2.33%$3.04$2.9090,421 shs$29.71 million06/20/2025$3.07$3.00-2.28%$3.10$2.9695,213 shs$30.42 million06/19/2025$3.07$3.07$3.07$2.9160,073 shs$31.13 million06/18/2025$2.86$3.07+7.34%$3.07$2.9160,073 shs$31.13 million06/17/2025$2.89$2.86-1.04%$2.98$2.8613,481 shs$29 million Related Companies Neumora Therapeutics Stock Price Chart Nuvectis Pharma Stock Price Chart Journey Medical Stock Price Chart BioAge Labs Stock Price Chart I-Mab Stock Price Chart Innate Pharma Stock Price Chart Caribou Biosciences Stock Price Chart Spero Therapeutics Stock Price Chart DiaMedica Therapeutics Stock Price Chart Immuneering Stock Price Chart Receive GRCE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Grace Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GRCE) was last updated on 7/18/2025 by MarketBeat.com Staff From Our PartnersElon Just Fired the IRS Agents Targeting Your SavingsElon Musk just fired 6,700 IRS agents — and exposed a war on your retirement. While D.C. scrambles to regai...Priority Gold | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored[ATTENTION] This Crypto Rocket Is About Launch…Every crypto bull market ends with a final surge — the window where fortunes are made fast. According to tw...Crypto Swap Profits | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Grace Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Grace Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
